Literature DB >> 12603832

Promotion of tau phosphorylation by MAP kinase Erk1/2 is accompanied by reduced cholesterol level in detergent-insoluble membrane fraction in Niemann-Pick C1-deficient cells.

Naoya Sawamura1, Jian-Sheng Gong, Ta-Yuan Chang, Katsuhiko Yanagisawa, Makoto Michikawa.   

Abstract

Niemann-Pick type C (NPC) disease is a cholesterol-storage disease accompanied by neurodegeneration with the formation of neurofibrillary tangles, the major component of which is the hyperphosphorylated tau. Here, we examined the mechanism underlying hyperphosphorylation of tau using mutant Chinese hamster ovary (CHO) cell line defective in NPC1 (CT43) as a tool. Immunoblot analysis revealed that tau was hyperphosphorylated at multiple sites in CT43 cells, but not in their parental cells (25RA) or the wild-type CHO cells. In CT43 cells, mitogen-activated protein (MAP) kinase Erk1/2 was activated and the specific MAPK inhibitor, PD98059, attenuated the hyperphosphorylation of tau. The amount of protein phosphatase 2A not bound to microtubules was decreased in CT43 cells. CT43 cells but not 25RA cells were amphotericin B-resistant, indicating that cholesterol level in the plasma membrane of CT43 is decreased. In addition, the level of cholesterol in the detergent-insoluble, low-density membrane (LDM) fraction of CT43 cells was markedly reduced compared with the other two types of CHO cells. As LDM domain plays critical role in signaling pathways, these results suggest that the reduced cholesterol level in LDM domain due to the lack of NPC1 may activate MAPK, which subsequently promotes tau phosphorylation in NPC1-deficient cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12603832     DOI: 10.1046/j.1471-4159.2003.01596.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease.

Authors:  Cinzia Marchi; Maria Pia Adorni; Paolo Caffarra; Nicoletta Ronda; Marco Spallazzi; Federica Barocco; Daniela Galimberti; Franco Bernini; Francesca Zimetti
Journal:  J Lipid Res       Date:  2019-06-05       Impact factor: 5.922

2.  Imaging of tau deposits in adults with Niemann-Pick type C disease: a case-control study.

Authors:  Victor L Villemagne; D Velakoulis; V Doré; S Bozinoski; C L Masters; C C Rowe; Mark Walterfang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-28       Impact factor: 9.236

3.  Animal models of human cerebellar ataxias: a cornerstone for the therapies of the twenty-first century.

Authors:  Mario Manto; Daniele Marmolino
Journal:  Cerebellum       Date:  2009-09       Impact factor: 3.847

4.  Deregulation of the phosphatidylinositol-3 kinase signaling cascade is associated with neurodegeneration in Npc1-/- mouse brain.

Authors:  Xiaoning Bi; Jihua Liu; Yueqin Yao; Michel Baudry; Gary Lynch
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

Review 5.  The role of cholesterol in pathogenesis of Alzheimer's disease: dual metabolic interaction between amyloid beta-protein and cholesterol.

Authors:  Makoto Michikawa
Journal:  Mol Neurobiol       Date:  2003-02       Impact factor: 5.590

6.  Lipid content of brain, brain membrane lipid domains, and neurons from acid sphingomyelinase deficient mice.

Authors:  Federica Scandroglio; Jagadish Kummetha Venkata; Nicoletta Loberto; Simona Prioni; Edward H Schuchman; Vanna Chigorno; Alessandro Prinetti; Sandro Sonnino
Journal:  J Neurochem       Date:  2008-09-18       Impact factor: 5.372

7.  Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus.

Authors:  Afia Akram; James Schmeidler; Pavel Katsel; Patrick R Hof; Vahram Haroutunian
Journal:  Brain Res       Date:  2010-01-14       Impact factor: 3.252

Review 8.  Lipid metabolism in Alzheimer's disease.

Authors:  Qiang Liu; Juan Zhang
Journal:  Neurosci Bull       Date:  2014-04-15       Impact factor: 5.203

Review 9.  Sigma-2 Receptor-A Potential Target for Cancer/Alzheimer's Disease Treatment via Its Regulation of Cholesterol Homeostasis.

Authors:  Kai Yang; Cheng Zeng; Changcai Wang; Meng Sun; Dan Yin; Taolei Sun
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

Review 10.  Cross-talk of membrane lipids and Alzheimer-related proteins.

Authors:  Jochen Walter; Gerhild van Echten-Deckert
Journal:  Mol Neurodegener       Date:  2013-10-22       Impact factor: 14.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.